![ATR kinase inhibitor AZD6738 potentiates CD8+ T cell–dependent antitumor activity following radiation]()
ATR kinase inhibitor AZD6738 potentiates CD8+ T cell–dependent antitumor activity following radiationVendetti, Frank P.; Karukonda, Pooja; Clump, David A.; Teo, Troy; Lalonde, Ronald; Nugent, Katriana; Ballew, Matthew; Kiesel, Brian F.; Beumer, Jan H.; Sarkar, Saumendra N.; Conrads, Thomas P.; O’Connor, Mark J.; Ferris, Robert L.; Tran, Phuoc T.; Delgoffe, Greg M.; Bakkenist, Christopher J. · Journal of Clinical Investigation · 2018